StreetAlpha
Bioventus Inc. · SEC Form 4

BVS Insider Trading

From SEC Form 416 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Bioventus Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $181K sold.

← BVS stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$181K2 sales · 2 insiders
Net−$181Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $76KDecJanFeb2026-03: sold $105KMarAprMayJunJulAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when BVS insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an BVS officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every BVS insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Mar 11, 2026Michelle McMurry-HeathDirectorSale12,000$8.79$105K44,997Mar 13Form 4
Dec 4, 2025Guy P NohraDirectorSale10,000$7.57$76K116,610Dec 8Form 4
Nov 7, 2025Michelle McMurry-HeathDirectorSale17,701$7.42$131K56,997Nov 10Form 4
Apr 11, 2025Katrina J ChurchSVP & Chief Compliance OfficerSale plan1,283$7.57$10K55,557Apr 15Form 4
Apr 11, 2025Anthony D'AdamioSVP & General CounselSale plan2,958$7.57$22K131,416Apr 15Form 4
Apr 11, 2025Mark Leonard SingletonSVP & CFOSale plan3,875$7.57$29K141,088Apr 15Form 4
Mar 24, 2025Mark Leonard SingletonSVP & CFOSale plan5,479$9.79$54K131,963Mar 25Form 4
Mar 17, 2025Anthony D'AdamioSVP & General CounselSale plan2,615$9.75$25K124,449Mar 18Form 4
Mar 17, 2025Katrina J ChurchSVP & Chief Compliance OfficerSale plan1,018$9.75$10K52,540Mar 18Form 4
Feb 18, 2025Katrina J ChurchSVP & Chief Compliance OfficerSale plan1,537$10.19$16K50,102Feb 20Form 4
Feb 18, 2025Anthony D'AdamioSVP & General CounselSale plan4,380$10.19$45K118,178Feb 20Form 4
Feb 18, 2025Mark Leonard SingletonSVP & CFOSale plan6,498$10.19$66K118,817Feb 20Form 4
Jan 13, 2025Robert E ClaypoolePresident and CEOSale plan28,786$9.10$262K64,964Jan 14Form 4
Dec 23, 2024Anthony D'AdamioSVP & General CounselSale plan5,848$10.53$62K109,578Dec 26Form 4
Dec 23, 2024Katrina J ChurchSVP & Chief Compliance OfficerSale plan2,535$10.53$27K47,264Dec 26Form 4
🔒 1 more trades. Create a free account or sign in to see them all.

BVS insider trading FAQ

Are BVS insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of BVS on the open market in 0 trades, and 2 sold $181K in 2 trades.

When did an BVS insider last buy shares?

There has been no open market insider purchase of BVS in the last two years.

When did an BVS insider last sell shares?

Michelle McMurry-Heath (Director) sold 12,000 shares for $105K on Mar 11, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice